DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Cui J, Philo L, Nguyen P. et al.
Sitagliptin vs. placebo for non-alcoholic fatty liver disease: a randomized controlled trial.
J Hepatol 2016;
65 (02) 369-376
We do not assume any responsibility for the contents of the web pages of other providers.